scholarly journals A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants

2021 ◽  
Vol 10 (1) ◽  
pp. 47
Author(s):  
Abdoulreza Esteghamati ◽  
Shirin Sayyahfar ◽  
Hossein Ghaemi ◽  
Mohammadamin Joulani ◽  
Yousef Moradi ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Antibody Level ◽  
Gestational Age ◽  
Post Vaccination ◽  
Appropriate For Gestational Age ◽  
Surface Antibody

scholarly journals Nursing Staff Knowledge of the Hepatitis B Virus Including Attitudes and Acceptance of Hepatitis B Vaccination: Development of an Effective Program

AAOHN Journal ◽  
2003 ◽  
Vol 51 (8) ◽  
pp. 347-352 ◽  
Author(s):  
Justine Mcgrane ◽  
Anthony Staines
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Antibody Level ◽  
Response Rate ◽  
Hepatitis B Vaccination ◽  
Post Vaccination ◽  
Charge Nurses ◽  
B Virus ◽  
Health Physician ◽  
Effective Program

Data for this study in a large tertiary referral teaching hospital in Dublin, Ireland were collected by anonymous self administered questionnaires. A total of 137 questionnaires were distributed to nurses working in five wards with a response rate of 88% (120). Objectives included identifying levels of awareness of the infectivity of the hepatitis B virus, ascertaining levels of knowledge of hepatitis B vaccination, and identifying attitudes resulting in acceptance of hepatitis B vaccine. Ninety seven respondents (82%) knew hepatitis B was 100 times more infective than HIV. Ninety eight respondents (83%) had completed a full course of hepatitis B immunizations. Ninety six respondents (93%) reported a hepatitis B antibody level on completion of the immunizations, 13 (14%) knew their actual titer, and 49 of 63 respondents (78%) reported immunity. Factors influencing decisions to accept vaccination included information related to the benefits of the vaccine from an occupational health physician or nurse and the vaccine being provided free of charge. Nurses in this study had an understanding of the hepatitis B infection. The number of nurses choosing to be vaccinated and having an antibody level test performed post-vaccination was high in this group. Most nurses in this study believed they were immune to hepatitis B even though a significant number did not know their hepatitis B antibody level.

Serum kallistatin level is decreased in women with preeclampsia

2021 ◽  
Vol 49 (1) ◽  
pp. 60-66
Author(s):  
Onur Güralp ◽  
Nevin Tüten ◽  
Koray Gök ◽  
Kübra Hamzaoglu ◽  
Huri Bulut ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Diastolic Blood Pressure ◽  
Gestational Age ◽  
Late Onset ◽  
Serine Proteinase ◽  
Serum Levels ◽  
Control Group ◽  
Positive Correlation ◽  
Uncomplicated Pregnancy ◽  
Appropriate For Gestational Age

AbstractObjectivesTo evaluate the serum levels of the serine proteinase inhibitor kallistatin in women with preeclampsia (PE).MethodsThe clinical and laboratory parameters of 55 consecutive women with early-onset PE (EOPE) and 55 consecutive women with late-onset PE (LOPE) were compared with 110 consecutive gestational age (GA)-matched (±1 week) pregnant women with an uncomplicated pregnancy and an appropriate for gestational age fetus.ResultsMean serum kallistatin was significantly lower in women with PE compared to the GA-matched-controls (27.74±8.29 ng/mL vs. 37.86±20.64 ng/mL, p<0.001); in women with EOPE compared to that of women in the control group GA-matched for EOPE (24.85±6.65 ng/mL vs. 33.37±17.46 ng/mL, p=0.002); and in women with LOPE compared to that of women in the control group GA-matched for LOPE (30.87±8.81 ng/mL vs. 42.25±22.67 ng/mL, p=0.002). Mean serum kallistatin was significantly lower in women with EOPE compared to LOPE (24.85±6.65 ng/mL vs. 30.87±8.81 ng/mL, p<0.001). Serum kallistatin had negative correlations with systolic and diastolic blood pressure, creatinine, and positive correlation with GA at sampling and GA at birth.ConclusionsSerum kallistatin levels are decreased in preeclamptic pregnancies compared to the GA-matched-controls. This decrease was also significant in women with EOPE compared to LOPE. Serum kallistatin had negative correlation with systolic and diastolic blood pressure, creatinine and positive correlation with GA at sampling and GA at birth.

Propensity-Matched Comparison of Very Preterm Small- and Appropriate-for-Gestational-Age Neonates

2021 ◽  
Author(s):  
Rajendra Prasad Anne ◽  
Venkateshwarulu Vardhelli ◽  
Tejo Pratap Oleti ◽  
Srinivas Murki ◽  
Gopireddy Murali Mohan Reddy ◽  
...  
Keyword(s):  
Gestational Age ◽  
Very Preterm ◽  
Appropriate For Gestational Age ◽  
Matched Comparison

Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys

2015 ◽  
Vol 143 (13) ◽  
pp. 2813-2821 ◽  
Author(s):  
H. F. GIDDING ◽  
D. MAHAJAN ◽  
J. REEKIE ◽  
A. R. LLOYD ◽  
D. E. DWYER ◽  
...  
Keyword(s):  
High Risk ◽  
General Population ◽  
Hepatitis B ◽  
Drug Users ◽  
Past Infection ◽  
Previous Episode ◽  
Hbv Vaccination ◽  
First Time ◽  
Male Prisoners ◽  
Surface Antibody

SUMMARYIn Australia, hepatitis B (HBV) vaccination is recommended for injecting drug users (IDUs), Indigenous adults and prisoners. We compared immunity to HBV in prisoners and the general population obtained from national serosurveys in 2007. Individuals with HBV surface antibody (HBsAb) positive sera were considered immune from past infection [HBV core antibody (HBcAb) positive] or from vaccination (HBcAb negative). Male prisoners aged 18–58 years had a higher HBsAb seroprevalence than the general population (46·4% vs. 39·4%, P = 0·061). Comparison of HBcAb results was possible for males aged 18–29 years. In this group, higher HBsAb seroprevalence was due to past infection (12·9% vs. 3·0%, P < 0·001), rather than vaccine-conferred immunity (35·3% vs. 43·4%, P = 0·097). All prisoner groups, but especially IDUs, those of Indigenous heritage or those with a previous episode of imprisonment had higher levels of immunity from past infection than the general population (19·3%, 33·0%, 17·1%, respectively, vs. 3·0%, P < 0·05). Indigenous prisoners, non-IDUs and first-time entrants had significantly lower levels of vaccine-conferred immunity than the general population (26·4%, 26·2% and 20·7% respectively vs. 43·4%, P < 0·05). Improving prison-based HBV vaccination would prevent transmission in the prison setting and protect vulnerable members of the community who are at high risk of both infection and entering the prison system.

Comparison of Phototherapy Results in Small-for-Gestational-Age and Appropriate-for-Gestational-Age Infants Weighing Less Than 2,000 Grams

PEDIATRICS ◽  
1985 ◽  
Vol 75 (2) ◽  
pp. 413-441
Author(s):  
Joan E. Hodgman ◽  
Paul Y. K. Wu ◽  
Nathaniel B. White ◽  
Dolores A. Bryla
Keyword(s):  
Birth Weight ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Congenital Defects ◽  
Intrauterine Growth ◽  
Appropriate For Gestational Age ◽  
Study Population ◽  
Similar Weight ◽  
Gestational Age At Birth ◽  
Evaluation Techniques

The infant who is small for gestational age (SGA) is more mature at birth than similar weight infants who are appropriate for gestational age (AGA). Whether the SGA infant behaves as does the larger gestationally equivalent infant, or whether there are specific changes related to intrauterine growth retardation is a matter of some interest in the understanding of the special needs of these infants. The National Institute of Child Health and Human Development (NICHD) phototherapy study provided a large newborn population for whom birth weight, gestational age at birth, and, thereby, intrauterine growth were carefully assessed. Infants who weighed 2,000 g or more at birth were included in the study only when they became jaundiced, whereas infants who weighed less than 2,000 g at birth were routinely entered into the study. Consequently, this report will be limited to the lowbirth-weight population selected by birth weight. Too few SGA babies were present in the groups with greater birth weight to allow meaningful comparisons. PATIENT SELECTIQN All infants whose birth weight was less than 2,000 g were entered into the study at 24 ± 12 hours. Those excluded from the study were: (1) infants who died before 24 hours, (2) infants with serious congenital defects, and (3) infants whose mothers refused consent for study. The study population consisted of 922 infants surviving at 24 hours. Gestational age was calculated from the first day of the last menstrual period obtained from maternal history and also by the evaluation techniques of Dubowitz.25 Intrauterine growth was determined by plotting birth weight and gestational age on the Denver Intrauterine Growth Curves8; infants below the 10th percentile were considered SGA.

Sign in / Sign up

Export Citation Format

Share Document